Your browser doesn't support javascript.
loading
Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China.
Zeng, Yanbing; Luo, Mingliang; Lin, Jianlin; He, Hanqing; Deng, Xuan; Xie, Shuyun; Fang, Ya.
Afiliación
  • Zeng Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, China.
  • Luo M; Key Laboratory of Health Technology Assessment of Fujian Province, School of Public Health, Xiamen University, Xiamen, China.
  • Lin J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, China.
  • He H; Key Laboratory of Health Technology Assessment of Fujian Province, School of Public Health, Xiamen University, Xiamen, China.
  • Deng X; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, China.
  • Xie S; Key Laboratory of Health Technology Assessment of Fujian Province, School of Public Health, Xiamen University, Xiamen, China.
  • Fang Y; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Hum Vaccin Immunother ; 16(4): 955-964, 2020 04 02.
Article en En | MEDLINE | ID: mdl-31769718

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Hepatitis B / Neoplasias Hepáticas Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans / Infant País/Región como asunto: Asia Idioma: En Revista: Hum Vaccin Immunother Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Hepatitis B / Neoplasias Hepáticas Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans / Infant País/Región como asunto: Asia Idioma: En Revista: Hum Vaccin Immunother Año: 2020 Tipo del documento: Article País de afiliación: China